REV1 is implicated in the development of carcinogen-induced lung cancer

Molecular Cancer Research

Volumn 7, Issue 2, 2009, Pages 247-254

  Dumstorf, Chad A ^a   Mukhopadhyay, Suparna ^a   Krishnan, Elangovan ^a   Haribabu, Bodduluri ^a,b   McGregor, W Glenn ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; CATION; DNA POLYMERASE REV1; POLYETHYLENEIMINE; RIBOZYME;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CANCER PREVENTION; CARCINOGENESIS; CONTROLLED STUDY; GENE TARGETING; IN VIVO STUDY; LASER MICRODISSECTION; LUNG CANCER; LUNG TUMOR; MALE; MOUSE; NONHUMAN; PLASMID; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ANIMALS; CARCINOGENS; FIBROBLASTS; LUNG NEOPLASMS; MALE; MICE; MUTAGENESIS; NUCLEOTIDYLTRANSFERASES; RNA, CATALYTIC; RNA, MESSENGER;

MUS;

EID: 61349138821     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0399     Document Type: Article

References (47)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Estensen RD, Jordan MM, Wiedmann TS, Galbraith AR, Steele VE, Wattenberg LW. Effect of chemopreventive agents on separate stages of progression of benzo [a] pyrene induced lung tumors in A/J mice. Carcinogenesis 2004;25:197-201.
3. McGregor WG, Chen RH, Lukash L, Maher VM, McCormick JJ. Cell cycle- dependent strand bias for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair-deficient cells. Mol Cell Biol 1991;11:1927-34.
4. Chen RH, Maher VM, McCormick JJ. Lack of a cell cycle-dependent strand bias for mutations induced in the HPRT gene by (+/-)-7β,8α-dihydroxy- 9α,10α- epoxy-7,8,9,10-tetrahydrobenzo (a) pyrene in excision repair-deficient human cells. Cancer Res 1991;51:2587-92.
5. Friedberg EC, Lehmann AR, Fuchs RP. Trading places: how do DNA polymerases switch during translesion DNA synthesis? Mol Cell 2005;18:499 -505.
6. Friedberg EC, Wagner R, Radman M. Specialized DNA polymerases, cellular survival, and the genesis of mutations. Science 2002;296:1627-30.
7. Watson NB, Mukhopadhyay S, McGregor WG. Translesion DNA replication proteins as molecular targets for cancer prevention. Cancer Lett 2006;241:13 -22.
8. Broomfield S, Hryciw T, Xiao W. DNA postreplication repair and mutagenesis in Saccharomyces cerevisiae. Mutat Res 2001;486:167-84.
9. Lawrence CW. Cellular roles of DNA polymerase ζ and Rev1 protein. DNA Repair (Amst) 2002;1:425-35.
10. Zhang Y, Wu X, Rechkoblit O, Geacintov NE, Taylor JS, Wang Z. Response of human REV1 to different DNA damage: preferential dCMP insertion opposite the lesion. Nucleic Acids Res 2002;30:1630 -8.
11. Nelson JR, Lawrence CW, Hinkle DC. Deoxycytidyl transferase activity of yeast REV1 protein. Nature 1996;382:729-31.
12. Nelson JR, Gibbs PE, Nowicka AM, Hinkle DC, Lawrence CW. Evidence for a second function for Saccharomyces cerevisiae Rev1p. Mol Microbiol 2000;37:549 -54.
13. Guo C, Fischhaber PL, Luk-Paszyc MJ, et al. Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis. EMBO J 2003;22:6621 -30.
14. Gibbs PE, Wang XD, Li Z, et al. The function of the human homolog of Saccharomyces cerevisiae REV1 is required for mutagenesis induced by UV light. Proc Natl Acad Sci U S A 2000;97:4186 -91.
15. Gibbs PE, McGregor WG, Maher VM, Nisson P, Lawrence CW. A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase ζ. Proc Natl Acad Sci U S A 1998;95:6876-80.
16. Xiao W, Lechler T, Chow BL, et al. Identification, chromosomal mapping and tissue-specific expression of hREV3 encoding a putative human DNA polymerase ζ. Carcinogenesis 1998;19:945-9.
17. Murakumo Y, Roth T, Ishii H, et al. A human REV7 homolog that interacts with the polymerase ζ catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2. J Biol Chem 2000;275:4391-7.
18. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, Kelloff GJ. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 1997;57:5489-92.
19. Wattenberg LW, Estensen RD. Studies of chemopreventive effects of budesonide on benzo [a] pyrene-induced neoplasia of the lung of female A/J mice. Carcinogenesis 1997;18:2015 -7.
20. Clark DR, Zacharias W, Panaitescu L, McGregor WG. Ribozyme-mediated REV1 inhibition reduces the frequency of UV-induced mutations in the human HPRT gene. Nucleic Acids Res 2003;31:4981 -8.
21. Mukhopadhyay S, Clark DR, Watson NB, Zacharias W, McGregor WG. REV1 accumulates in DNA damage-induced nuclear foci in human cells and is implicated in mutagenesis by benzo [a] pyrenediolepoxide. Nucleic Acids Res 2004;32:5820-6.
22. Good PD, Krikos AJ, Li SX, et al. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther 1997;4:45 -54.
23. Luukkonen BG, Seraphin B. Construction of an in vivo -regulated U6 snRNA transcription unit as a tool to study U6 function. RNA 1998;4:231-8.
24. Lai D, Fu L, Weng S, et al. Blocking caspase-3 activity with a U6 SnRNA promoter-driven ribozyme enhances survivability of CHO cells cultured in low serum medium and production of interferon-β. Biotechnol Bioeng 2004;85:20 -8.
25. Jansen JG, Tsaalbi-Shtylik A, Langerak P, et al. The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis. Nucleic Acids Res 2005;33:356 -65.
26. Ross AL, Simpson LJ, Sale JE. Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains ofREV1. Nucleic Acids Res 2005;33:1280-9.
27. Tissier A, Kannouche P, Reck MP, Lehmann AR, Fuchs RP, Cordonnier A. Co-localization in replication foci and interaction of human Y-family members, DNA polymerase pol η and REVl protein. DNA Repair (Amst) 2004;3:1503 -14.
28. Jansen JG, Fousteri MI, de WN. Send in the clamps: control of DNA translesion synthesis in eukaryotes. Mol Cell 2007;28:522 -9.
29. Wang M, Devereux TR, Vikis HG, et al. Pol ι is a candidate for the mouse pulmonary adenoma resistance 2locus, a major modifier of chemically induced lung neoplasia. Cancer Res 2004;64:1924-31.
30. Dumstorf CA, Clark AB, Lin Q, et al. Participation of mouse DNA polymerase ι in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer. Proc Natl Acad Sci U S A 2006;103:18083 -8.
31. Densmore CL. Polyethyleneimine-based gene therapy by inhalation. Expert Opin Biol Ther 2003;3:1083 -92.
32. Densmore CL. Advances in noninvasive pulmonary gene therapy. Curr Drug Deliv 2006;3:55 -63.
33. Klink D, Schindelhauer D, Laner A, et al. Gene delivery systems-gene therapy vectors for cystic fibrosis. J Cyst Fibros 2004;3 Suppl 2:203 -12.
34. Schwiebert LM. Cystic fibrosis, gene therapy, and lung inflammation: for better or worse? Am J Physiol Lung Cell Mol Physiol 2004;286:L715-6.
35. Gautam A, Densmore CL, Waldrep JC. Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther 2001;8:254-7.
36. Bauer AK, Dwyer-Nield LD, Hankin JA, Murphy RC, Malkinson AM. The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice. Toxicology 2001;169:1 -15.
37. Gautam A, Waldrep JC, Kleinerman ES, et al. Aerosol gene therapy for metastatic lung cancer using PEI-p53 complexes. Methods Mol Med 2003;75:607-18.
38. Gautam A, Waldrep JC, Densmore CL, etal. Growth inhibition of established B16-10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin. Gene Ther 2002;9:353 -7.
39. Gautam A, Densmore CL, Waldrep JC. Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes. Mol Ther 2000;2:318 -23.
40. Rudolph C, Ortiz A, Schillinger U, Jauernig J, Plank C, Rosenecker J. Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application. J Gene Med 2005;7:59-66.
41. Gautam A, Densmore CL, Xu B, Waldrep JC. Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol Ther 2000;2:63 -70.
42. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823 -35.
43. Rudolph C, Schillinger U, Ortiz A, et al. Aerosolized nanogram quantities of plasmid DNA mediate highly efficient gene delivery to mouse airway epithelium. Mol Ther 2005;12:493 -501.
44. Ohkumo T, Kondo Y, Yokoi M, et al. UV-B radiation induces epithelial tumors in mice lacking DNA polymerase η and mesenchymal tumors in mice deficient for DNA polymerase ι. Mol Cell Biol 2006;26:7696-706.
45. Zuker M, Jacobson AB. "Well-determined" regions in RNA secondary structure prediction: analysis of small subunit ribosomal RNA. Nucleic Acids Res 1995;23:2791 -8.
46. Diaz M, Watson NB, Turkington G, Verkoczy LK, Klinman NR, McGregor WG. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase ζ. Mol Cancer Res 2003;1:836-47.
47. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCRandthe 2(-ΔΔC(T)) method. Methods 2001;25:402-8.